Patents Assigned to Replimune Limited GB
  • Modified oncolytic virus
    Patent number: 12465639
    Abstract: The present invention relates to an oncolytic virus comprising: (i) a fusogenic protein-encoding gene and (ii) an immune stimulatory molecule-encoding gene.
    Type: Grant
    Filed: September 6, 2023
    Date of Patent: November 11, 2025
    Assignee: Replimune Limited GB
    Inventor: Robert Stuart Coffin